Sun Xiaoqing, Yin Jianping, Starovasnik Melissa A, Fairbrother Wayne J, Dixit Vishva M
Department of Molecular Oncology, Genentech, Inc., South San Francisco, California 94080, USA.
J Biol Chem. 2002 Mar 15;277(11):9505-11. doi: 10.1074/jbc.M109488200. Epub 2001 Dec 4.
Receptor-interacting protein (RIP), a Ser/Thr kinase component of the tumor necrosis factor (TNF) receptor-1 signaling complex, mediates activation of the nuclear factor kappaB (NF-kappaB) pathway. RIP2 and RIP3 are related kinases that share extensive sequence homology with the kinase domain of RIP. Unlike RIP, which has a C-terminal death domain, and RIP2, which has a C-terminal caspase activation and recruitment domain, RIP3 possesses a unique C terminus. RIP3 binds RIP through this unique C-terminal segment to inhibit RIP- and TNF receptor-1-mediated NF-kappaB activation. We have identified a unique homotypic interaction motif at the C terminus of both RIP and RIP3 that is required for their association. Sixty-four amino acids within RIP3 and 88 residues within RIP are sufficient for interaction of the two proteins. This interaction is a prerequisite for RIP3-mediated phosphorylation of RIP and subsequent attenuation of TNF-induced NF-kappaB activation.
受体相互作用蛋白(RIP)是肿瘤坏死因子(TNF)受体-1信号复合物的丝氨酸/苏氨酸激酶成分,介导核因子κB(NF-κB)途径的激活。RIP2和RIP3是相关激酶,与RIP的激酶结构域具有广泛的序列同源性。与具有C端死亡结构域的RIP和具有C端半胱天冬酶激活和募集结构域的RIP2不同,RIP3具有独特的C末端。RIP3通过这个独特的C末端片段与RIP结合,以抑制RIP和TNF受体-1介导的NF-κB激活。我们在RIP和RIP3的C末端鉴定了一个独特的同型相互作用基序,这是它们相互结合所必需的。RIP3内的64个氨基酸和RIP内的88个残基足以实现两种蛋白质的相互作用。这种相互作用是RIP3介导的RIP磷酸化以及随后TNF诱导的NF-κB激活减弱的先决条件。